You searched for "proptosis"
New Clinical Specialist for the North and National Refractive Specialist
Surgitrac is pleased to announce the appointment of Jessica Seers as Clinical Specialist for the North and National Refractive Specialist for lenses. With a strong clinical background and a passion for ophthalmology, Jessica steps into a dual role that supports...SCOPE Announces 2025 Independent Prescriber Bursary Award Winners
SCOPE is proud to announce the winners of its 2025 Independent Prescriber (IP) Bursary Awards, an initiative now in its fourth year. Designed to support optometrists in gaining IP qualifications by covering course fees, the awards continue to attract strong...Advancing Eyecare (AEC) acquires Birmingham Optical Group
Advancing Eyecare (AEC), a leading North American provider of ophthalmic instruments, has acquired Birmingham Optical Group, a top UK supplier of optical equipment and services. The terms of the deal were not disclosed. With over 60 years of industry experience,...Oertli launches the OS 4 UpTM surgical platform along with new instruments for retina and cataract surgery
Berneck, 4th September 2025 – Oertli Instrumente AG presented its surgical platform, the OS 4 UpTM, to the attendees of the Euretina and ESCRS congresses. The platform introduces forward-thinking solutions for vitreoretinal and cataract surgery and is complemented by new...Surgitrac Instruments at the 43rd Congress of the ESCRS: A Successful Event in Copenhagen
Surgitrac Instruments was proud to exhibit at the 43rd Congress of the ESCRS in the beautiful city of Copenhagen. This year’s congress was a fantastic opportunity to connect with ophthalmic professionals from around the world, share ideas, and showcase our...Glaukos Launches iStent infinite® in the UK Following MDR Approval
Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...
Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report
Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...MacuMira and Keeler announce strategic partnership to expand dry AMD therapy
Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the agreement, Keeler will manufacture the MacuMira device and lead its...BBC News Highlights New Approach to Treating Ocular Hypotony
Ocular hypotony has been in the spotlight following recent BBC News coverage highlighting how new clinical research is delivering meaningful benefits for patients affected by this sight threatening condition. The feature draws attention to a newly published study from the...
Outcomes of office and home-based training vs part-time occlusion for intermittent exotropia management
This study aimed to compare patch therapy with non-surgical treatment options for intermittent exotropia (IXT) using a synoptophore with/without simultaneous active orthoptic treatment and a maintenance treatment using computer-based gaming software. This 3-group trial recruited 72 patients. Intervention 1 (N=24)...
